Company in the news: Aviva
Aviva has made a play for life insurer Friends Life. Phil Oakley explains what investors should do next.
So Aviva (LSE: AV) has decided to buy UK life insurance company Friends Life (LSE: FLG). Instead of paying cash, it is offering 0.74 of its own shares for each Friends Life share, valuing them at 374p each. The key question is: does this deal stack up for both sets of shareholders?
If Friends Life shareholders choose to sell up, they're getting a decent uplift compared to where the shares were trading before the deal. But some are more sceptical about what Friends Life does for Aviva.
Unsurprisingly, Aviva's management is bullish, saying the company can save £225m in annual costs and boost cash flow by £600m in the future.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The deal also gives them five million extra customers to sell more products to, while the all-share deal will strengthen Aviva's financial position.
On top of this, Aviva plans to ramp up its dividend payments to shareholders by raising the payout from 35% of profits to 50%.
But combining two business is always easier on paper than in practice. Time will tell, of course, but given the risk, Aviva shares don't look that cheap right now on a price-to-book-value ratio of 1.7 times and a yield of 3.3%. Buying Friends Life may pay off handsomely, but I wouldn't chase the shares.
Verdict: hold
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Phil spent 13 years as an investment analyst for both stockbroking and fund management companies.
After graduating with a MSc in International Banking, Economics & Finance from Liverpool Business School in 1996, Phil went to work for BWD Rensburg, a Liverpool based investment manager. In 2001, he joined ABN AMRO as a transport analyst. After a brief spell as a food retail analyst, he spent five years with ABN's very successful UK Smaller Companies team where he covered engineering, transport and support services stocks.
In 2007, Phil joined Halbis Capital Management as a European equities analyst. He began writing for MoneyWeek in 2010.
-
Shareholder group backs lawsuit against Hargreaves Lansdown by Woodford investors
More than 5,000 people who invested in Neil Woodford's collapsed equity income product are taking Hargreaves Lansdown to court
By Chris Newlands Published
-
Should you bet on US stocks?
You don’t have to be bearish on US stocks to worry that they are now such a large share of global indices
By Cris Sholto Heaton Published
-
What pension providers don't tell you about your retirement money
Check the small print from your pension provider or risk losing thousands.
By Merryn Somerset Webb Published
-
Aviva: One for income investors to tuck away
Tips Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. Rupert Hargreaves delves into the numbers.
By Rupert Hargreaves Last updated
-
Aviva’s jab at preference shares leaves scars
Features A backlash has forced Aviva to think again about scrapping its preference shares – but the damage is done, says John Stepek.
By John Stepek Published
-
Aviva has had a rethink on preference shares, but what now?
Features Aviva’s abandoned proposal to cancel £450m of preference shares has left a lot of people out of pocket. This isn’t over, says Merryn Somerset Webb. Not by a long chalk.
By Merryn Somerset Webb Published
-
Buy-to-letters set up shop
Features Buy-to-let landlords are turning to commercial property in their search for higher yields and greater stability. Sarah Moore explains.
By Sarah Moore Published
-
Aviva agrees Friends Life deal
Features Aviva, Britain’s second-biggest insurer, has reached a preliminary deal to buy smaller rival Friends Life.
By moneyweek Published